Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.46 | N/A |
| PEG Ratio (TTM) | 13.44 | N/A |
| P/S Ratio (TTM) | 2.54 | N/A |
| P/B Ratio (TTM) | 1.00 | N/A |
| P/FCF Ratio (TTM) | 14.16 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.03 | N/A |
| Price to 5YR AVG FCF Ratio | 11.91 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.71% | N/A |
| ROE (TTM) | 5.83% | N/A |
| Net Profit Margin (TTM) | 14.64% | N/A |
| ROIC 5YR AVG | 15.07% | N/A |
Growth (93%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 68.32% | 36,841.81% | 22,094.28% |
| Revenue | 14.45% | 8.91% | 20.87% |
| Net Income | 63.84% | 21.53% | 7.00% |
| Cash Flow | 63.40% | 28.85% | 20.79% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.03 | N/A |
| Quick Ratio (TTM) | 0.03 | N/A |
| D/E Ratio (TTM) | 0.10 | N/A |
| Interest Coverage (TTM) | 0.58 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 1.17 | N/A |
| Shares Outstanding Growth 5YR AVG | 8.34% | N/A |